Legal Representation
Attorney
Nicole Gage
USPTO Deadlines
Next Deadline
2002 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250708)
Due Date
July 08, 2031
Grace Period Ends
January 08, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 8, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 8, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 20, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 20, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 14, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 21, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 17, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 16, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 15, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Small molecule chemical structures, namely, reagents for adhering radioactive agents to pharmaceutical compounds for scientific purposes; chemical agents for chelating radioisotopes
First Use Anywhere:
Jul 7, 2022
First Use in Commerce:
Jul 19, 2022
Class 005
Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers
First Use Anywhere:
May 31, 2023
First Use in Commerce:
May 31, 2023
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
No claim is made to the exclusive right to use "Therapeutics" apart from the mark as shown.